CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2018	Mar. 31, 2017
Current Assets
Cash	$ 60,934	$ 212,637
Accounts receivable, net	12,386	5,677
Inventory	29,074	22,699
Prepaids and other current assets	124,455	16,920
Total Current Assets	226,849	257,933
Property and equipment, net	4,441
Equity investments	468,537	300,000
Intangible asset, net		1,118,179
Other asset	5,500
TOTAL ASSETS	705,327	1,676,112
Current Liabilities
Accounts payable	21,846	12,297
Accrued expenses	14,039	19,287
Total Current Liabilities	35,885	31,584
Commitments and Contingencies
Stockholders' Equity
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at March 31, 2018 and 2017
Common stock; $0.00001 par value; 200,000,000 shares authorized; 10,499,610 and 15,247,600 issued and outstanding at March 31, 2018 and 2017, respectively	105	152
Additional paid in capital	3,054,297	1,742,472
Common stock to be issued, 200,000 and 150,000 shares at March 31, 2018 and 2017, respectively	526,000	426,000
Accumulated deficit	(2,901,933)	(525,832)
Total Applied BioSciences Corp. Stockholders' Equity	678,469	1,642,792
Non-controlling (deficit) interest	(9,027)	1,736
Total Stockholders' Equity	669,442	1,644,528
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 705,327	$ 1,676,112